Journal Highlight : Molecular Oncology
The journal welcomes scholarly contributions related to the molecular and cellular mechanisms underlying cancer development, progression, diagnosis, and treatment. This section focuses on research that advances the understanding of cancer biology at the molecular level and supports the development of innovative diagnostic, prognostic, and therapeutic strategies in oncology.
The journal encourages submissions in areas including Cancer Genomics, Cancer Proteomics, Molecular Pathways in Cancer, Tumor Biology, Cancer Genetics, Epigenetics in Oncology, Cell Signaling and Cancer Progression, Tumor Microenvironment, Cancer Stem Cells, and Molecular Biomarkers. Research related to Oncogenes and Tumor Suppressor Genes, DNA Damage and Repair Mechanisms, Molecular Diagnostics, Liquid Biopsy Technologies, Circulating Tumor Biomarkers, and Translational Molecular Oncology is also welcomed.
Submissions focusing on Targeted Cancer Therapies, Precision Oncology, Immuno-Oncology, Drug Resistance Mechanisms, Pharmacogenomics, Molecular Imaging, AI and Bioinformatics in Cancer Research, and Next-Generation Sequencing Applications are encouraged. The journal also welcomes studies investigating molecular determinants of cancer metastasis, therapeutic response, and personalized treatment strategies across different cancer types.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Experimental Studies, Translational Research Articles, Clinical-Molecular Correlation Studies, Case Reports, and Technology and Methodology Reports that contribute to advancements in molecular oncology and cancer research.
Through this focus area, the journal aims to support research that deepens the molecular understanding of cancer, advances precision medicine and targeted therapies, improves diagnostic and prognostic capabilities, and contributes to innovative and evidence-based oncology practices worldwide.
